An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits

Clinical trial NCT00219245 · COMPLETED

Trial details

NCT number: NCT00219245
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Traumatic Brain Injury With Persistent Cognitive Deficits

Start date: 2002-11-01
Primary completion: 2005-01-01
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.